Document ID: chunk:federal_register_of_legislation:F2023L01747:schedule:1:p8
Version: federal_register_of_legislation:F2023L01747
Segment Type: schedule
Provision Reference: sch 1 (pt 8/31)
Character Range: 24313–28566

60   0  60
                      Capsule 110 mg (as mesilate)  Oral     Pradaxa            BY  MP NP  C4269 C4369 C4381 C4402 C14308  P4381   20   0  10
                                                                                    MP NP  C4269 C4369 C4381 C4402 C14308  P4369   20   1  10
                                                          a  ARX-Dabigatran     XT  MP NP  C4269 C4402 C14308              P4402   60   0  60
                                                          a  Dabigatran Sandoz  SZ  MP NP  C4269 C4402 C14308              P4402   60   0  60
                                                          a  Pradaxa            BY  MP NP  C4269 C4369 C4381 C4402 C14308  P4402   60   0  60
                                                          a  ARX-Dabigatran     XT  MP NP  C4269 C4402 C14308              P4269   60   5  60
                                                          a  Dabigatran Sandoz  SZ  MP NP  C4269 C4402 C14308              P4269   60   5  60
                                                          a  Pradaxa            BY  MP NP  C4269 C4369 C4381 C4402 C14308  P4269   60   5  60
                                                          a  ARX-Dabigatran     XT  MP NP  C4269 C4402 C14308              P14308  120  5  60
                                                          a  Dabigatran Sandoz  SZ  MP NP  C4269 C4402 C14308              P14308  120  5  60
                                                          a  Pradaxa            BY  MP NP  C4269 C4369 C4381 C4402 C14308  P14308  120  5  60
                      Capsule 150 mg (as mesilate)  Oral  a  ARX-Dabigatran     XT  MP NP  C4269 C14308                    P4269   60   5  60
                                                          a  Dabigatran Sandoz  SZ  MP NP  C4269 C14308                    P4269   60   5  60
                                                          a  Pradaxa            BY  MP NP  C4269 C14308                    P4269   60   5  60
                                                          a  ARX-Dabigatran     XT  MP NP  C4269 C14308                    P14308  120  5  60
                                                          a  Dabigatran Sandoz  SZ  MP NP  C4269 C14308                    P14308  120  5  60
                                                          a  Pradaxa            BY  MP NP  C4269 C14308                    P14308  120  5  60

     [33]               Schedule 1, Part 1, entry for Deferasirox in the form Tablet, dispersible, 125 mg
     substitute:
   Tablet, dispersible, 125 mg  Oral  a  Deferasirox Juno       JU  MP  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7385 P8326 P8328 P8329 P9222 P9258 P9302  168  2  28     D(100)
                                      a  Pharmacor Deferasirox  CR  MP  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7385 P8326 P8328 P8329 P9222 P9258 P9302  168  2  28     D(100)
                                      a  Deferasirox Juno       JU  MP  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7374 P7375                                168  5  28     D(100)
                                      a  Pharmacor Deferasirox  CR  MP  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7374 P7375                                168  5  28     D(100)

     [34]               Schedule 1, Part 1, entry for Deferasirox in the form Tablet, dispersible, 250 mg
     substitute:
   Tablet, dispersible, 250 mg  Oral  a  Deferasirox Juno       JU  MP  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7385 P8326 P8328 P8329 P9222 P9258 P9302  168  2  28     D(100)
                                      a  Pharmacor Deferasirox  CR  MP  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7385 P8326 P8328 P8329 P9222 P9258 P9302  168  2  28     D(100)
                                      a  Deferasirox Juno       JU  MP  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7374 P7375                                168  5  28     D(100)
                                      a  Pharmacor Deferasirox  CR  MP  C7374 C7375 C7385 C8326 C8328 C8329 C9222 C9258 C9302  P7374 P7375                                168  5  28     D(100)

     [35]               Schedule 1, Part